These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 18466052)

  • 21. Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load.
    Koson P; Zilka N; Kovac A; Kovacech B; Korenova M; Filipcik P; Novak M
    Eur J Neurosci; 2008 Jul; 28(2):239-46. PubMed ID: 18702695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel therapeutics based on tau/microtubule dynamics: WO2008084483.
    Alonso Adel C; Corbo CP
    Expert Opin Ther Pat; 2009 Sep; 19(9):1335-8. PubMed ID: 19555159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Highly populated turn conformations in natively unfolded tau protein identified from residual dipolar couplings and molecular simulation.
    Mukrasch MD; Markwick P; Biernat J; Bergen Mv; Bernadó P; Griesinger C; Mandelkow E; Zweckstetter M; Blackledge M
    J Am Chem Soc; 2007 Apr; 129(16):5235-43. PubMed ID: 17385861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in experimental modeling of the assembly of tau filaments.
    Ko LW; DeTure M; Sahara N; Chihab R; Vega IE; Yen SH
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):125-39. PubMed ID: 15615632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conformational changes specific for pseudophosphorylation at serine 262 selectively impair binding of tau to microtubules.
    Fischer D; Mukrasch MD; Biernat J; Bibow S; Blackledge M; Griesinger C; Mandelkow E; Zweckstetter M
    Biochemistry; 2009 Oct; 48(42):10047-55. PubMed ID: 19769346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BAG-1M is up-regulated in hippocampus of Alzheimer's disease patients and associates with tau and APP proteins.
    Elliott E; Laufer O; Ginzburg I
    J Neurochem; 2009 May; 109(4):1168-78. PubMed ID: 19317853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The progress in proteomics researches of Alzheimer's disease].
    Liu B; Wang XL
    Sheng Li Ke Xue Jin Zhan; 2006 Jan; 37(1):11-6. PubMed ID: 16683538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The natively unfolded character of tau and its aggregation to Alzheimer-like paired helical filaments.
    Jeganathan S; von Bergen M; Mandelkow EM; Mandelkow E
    Biochemistry; 2008 Oct; 47(40):10526-39. PubMed ID: 18783251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Abeta/tau soluble complexes to solve the insolvable question of Alzheimer's disease primary cause].
    Epelbaum J
    Med Sci (Paris); 2006 May; 22(5):462-3. PubMed ID: 16687104
    [No Abstract]   [Full Text] [Related]  

  • 30. A putative role for cell cycle-related proteins in microtubule-based neuroplasticity.
    Schmetsdorf S; Arnold E; Holzer M; Arendt T; Gärtner U
    Eur J Neurosci; 2009 Mar; 29(6):1096-107. PubMed ID: 19302146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SUMO-1 immunoreactivity co-localizes with phospho-Tau in APP transgenic mice but not in mutant Tau transgenic mice.
    Takahashi K; Ishida M; Komano H; Takahashi H
    Neurosci Lett; 2008 Aug; 441(1):90-3. PubMed ID: 18586401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Early diagnosis of Alzheimer's disease].
    Derouesné C
    Rev Prat; 1989 Feb; 39(6):457-61. PubMed ID: 2704958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of Alzheimer's-like paired helical filaments from the core domain of tau protein using solid-state NMR spectroscopy.
    Andronesi OC; von Bergen M; Biernat J; Seidel K; Griesinger C; Mandelkow E; Baldus M
    J Am Chem Soc; 2008 May; 130(18):5922-8. PubMed ID: 18386894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tau is actin up in Alzheimer's disease.
    Gallo G
    Nat Cell Biol; 2007 Feb; 9(2):133-4. PubMed ID: 17268475
    [No Abstract]   [Full Text] [Related]  

  • 35. [Interest of CSF beta-amyloid1-42 and t-tau protein level determinations for the diagnosis of Alzheimer's disease].
    Smach MA; Charfeddine B; Lammouchi T; Dridi H; Ben Othman L; Bennamou S; Limem K
    Ann Biol Clin (Paris); 2008; 66(5):531-5. PubMed ID: 18957342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
    Zhang Q; Zhang X; Sun A
    Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CSF APPs alpha and phosphorylated tau protein levels in mild cognitive impairment and dementia of Alzheimer's type.
    Fellgiebel A; Kojro E; Müller MJ; Scheurich A; Schmidt LG; Fahrenholz F
    J Geriatr Psychiatry Neurol; 2009 Mar; 22(1):3-9. PubMed ID: 19073834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alcoholic liver disease: molecular-pathologic aspects.
    Zatloukal K; Kenner L; Preisegger KH; Denk H
    Verh Dtsch Ges Pathol; 1995; 79():28-35. PubMed ID: 8600692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study.
    Hampel H; Ewers M; Bürger K; Annas P; Mörtberg A; Bogstedt A; Frölich L; Schröder J; Schönknecht P; Riepe MW; Kraft I; Gasser T; Leyhe T; Möller HJ; Kurz A; Basun H
    J Clin Psychiatry; 2009 Jun; 70(6):922-31. PubMed ID: 19573486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau(181P).
    Koopman K; Le Bastard N; Martin JJ; Nagels G; De Deyn PP; Engelborghs S
    Neurochem Int; 2009 Sep; 55(4):214-8. PubMed ID: 19524111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.